Literature DB >> 29282564

Primary rhegmatogenous retinal detachment: risk factors for macular involvement.

Jelena Potic1,2, Ciara Bergin3, Clarice Giacuzzo3, Alejandra Daruich3, Lazaros Konstantinidis3, Thomas J Wolfensberger3.   

Abstract

PURPOSE: Rhegmatogenous retinal detachment (RD) has diagnostically been divided into macula-OFF or macula-ON. The aim of this study was to describe the demographics and primary outcome of patients with RD following surgery with respect to the macular status, and to determine risk factors for macular involvement.
METHODS: This prospective, observational, mono-centric cohort study was conducted at the Jules-Gonin Eye Hospital, from February 2015 until March 2017. The study included 194 eligible patients with primary RD. All patients underwent surgical treatment after baseline clinical examination. The dataset was analyzed using descriptive and analytic statistics.
RESULTS: A total of 52.6% (102/194) of patients presented with macula-OFF RD. Mean age was 63.9 ± 12.0 vs. 59.7 ± 11.2 years in the OFF and ON group, respectively. There were 129 men (66.5%) and 65 (33.5%) women, and there were significantly more right eyes affected [right vs. left eyes 123 (63.4%) vs. 71 (36.6%), p = 0.000]. Significantly more myopes (<-3D) presented with a macula-ON RD (p = 0.04). There were more phakic patients in the cohort (55.7%), and phakic eyes were more likely to present with macula-ON RD (p = 0.01). Multivariate modeling showed that pseudophakic lens status and eyes with axial length less than 25 mm (p = 0.06) are independent predictive factors for macula-OFF RD (p = 0.02), whereas sex and laterality were not risk factors for macular involvement.
CONCLUSION: Pseudophakic lens status and axial length < 25 mm are independent predictive factors for macula-OFF RD. While pseudophakic lens status is a recognized risk factor for RD, shorter axial length has not been previously identified as a risk factor for the macula-OFF RD.

Entities:  

Keywords:  Axial length; Lens status; Macula status; Retinal detachment

Mesh:

Year:  2017        PMID: 29282564     DOI: 10.1007/s00417-017-3880-x

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  7 in total

Review 1.  The urgency of surgical treatment for rhegmatogenous retinal detachment.

Authors:  Nicolas Feltgen; Josep Callizo; Lars-Olof Hattenbach; Hans Hoerauf
Journal:  Ophthalmologe       Date:  2021-03-22       Impact factor: 1.059

Review 2.  [The urgency of surgical treatment for rhegmatogenous retinal detachment].

Authors:  Nicolas Feltgen; Josep Callizo; Lars-Olof Hattenbach; Hans Hoerauf
Journal:  Ophthalmologe       Date:  2020-09       Impact factor: 1.059

3.  Clinical observation of vitrectomy combined with endolaser photocoagulation at the edge of posterior scleral staphyloma for macular hole retinal detachment in high myopia.

Authors:  Xiao-Tian Zhang; Jing-Xian Wang; Song Chen
Journal:  Int J Ophthalmol       Date:  2022-10-18       Impact factor: 1.645

4.  The risk factors of the progression of rhegmatogenous retinal detachment on patients with the fourteen-day quarantine in the early period of COVID-19 outbreak.

Authors:  Meng Zhao; Jipeng Li; Haicheng She; Ningpu Liu
Journal:  BMC Ophthalmol       Date:  2021-05-15       Impact factor: 2.209

5.  Impact of the COVID-19 pandemic on characteristics of retinal detachments: the Canadian experience.

Authors:  Parnian Arjmand; Fahmeeda Murtaza; Arshia Eshtiaghi; Marko M Popovic; Peter J Kertes; Kenneth T Eng
Journal:  Can J Ophthalmol       Date:  2020-12-26       Impact factor: 1.882

6.  Trends in the Clinical Presentation of Primary Rhegmatogenous Retinal Detachments During the First Year of the COVID-19 Pandemic.

Authors:  Rusdeep Mundae; Adrian Velez; Guneet S Sodhi; Peter J Belin; James M Kohler; Edwin H Ryan; Peter H Tang
Journal:  Am J Ophthalmol       Date:  2021-11-19       Impact factor: 5.488

7.  Risk factors for retinal breaks during macular hole surgery.

Authors:  Masashi Sakamoto; Izumi Yoshida; Ryuya Hashimoto; Hidetaka Masahara; Takatoshi Maeno
Journal:  Clin Ophthalmol       Date:  2018-10-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.